Skip to content

Whole heart 4D flow in the diagnosis of heart failure with preserved ejection fraction and the prediction of adverse prognostic factors

Whole heart 4D flow in the diagnosis of heart failure with preserved ejection fraction and the prediction of adverse prognostic factors

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026783
Enrollment
Unknown
Registered
2019-10-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure with preserved Ejection Fraction

Interventions

Gold Standard:At present, there is no gold standard to diagnose HFPEF in clinic, so this study takes clinical diagnosis of HFPEF as reference standard, that is, 1) it has typical symptoms and signs of
2) LVEF >= 50%, and left ventricle is not large
3) diastolic dysfunction of left ventricle co
Index test:1. Direct Flow
2. Delayed Ejection
3. Retained inflow
4. Residual Volume.

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The admission criteria of HFpEF patients were as follows: 1) they had typical symptoms and signs of heart failure; 2) LVEF >= 50%, and left ventricle was not large; 3) diastolic dysfunction of left ventricle confirmed by tissue Doppler: mean e '= 13. 2. Criteria for HFrEF patients: 1) typical symptoms and signs of heart failure, more than 3 months; 2) LVEF < 40%. 3. The admission criteria of healthy recipients: 1) the patients and their families voluntarily accept the examination; 2) the research scheme will be implemented after being approved by the hospital ethics committee.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for HFpEF and HFrEF patients: heart valve disease, pericardial disease, hypertrophic cardiomyopathy, restrictive cardiomyopathy, any contraindications of CMR scan, aged less than 20 years or more than 70 years, malignant tumor patients, pregnant women. 2. Exclusion criteria for healthy volunteers include: 1) history of hypertension, whether or not using drugs; 2) history of diabetes, whether or not using drugs; 3) history of any cardiovascular disease, including ischemic and non ischemic cardiomyopathy, valvular heart disease, congenital heart disease; 4) any contraindications of CMR scanning; 5) age less than 20 years or more than 70 years; 6) malignant Tumor patients; 7) pregnant women.

Design outcomes

Primary

MeasureTime frame
directe flow;Delayed Ejection;Retained inflow;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
Residual Volume;

Countries

China

Contacts

Public ContactTang Guangyu

Shanghai Tenth People's Hospital

tgy17@126.com+86 021-66306242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026